Valuation: DocMorris AG

Market Cap 497M 614M 533M 456M 863M 58.36B 872M 5.86B 2.29B 29.17B 2.3B 2.25B 96.67B P/E 2026 *
-6.48x
P/E 2027 * -13x
Enterprise Value 697M 861M 747M 640M 1.21B 81.87B 1.22B 8.21B 3.21B 40.93B 3.23B 3.16B 136B EV / Sales 2026 *
0.56x
EV / Sales 2027 * 0.53x
Free-Float
62.19%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 61 28/04/2022
Director of Finance/CFO 56 01/10/2024
Chief Tech/Sci/R&D Officer - 01/11/2024
Director TitleAgeSince
Chairman 68 28/04/2022
Director/Board Member 53 23/05/2019
Director/Board Member 56 01/01/2021
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00% - - 614M
+0.41%-1.60%-22.75%-26.57% 15.94B
+0.56%+0.56%-27.66%-35.30% 7.4B
-0.58%-10.22%-24.94%-10.05% 6.07B
-1.19%-0.13%-8.78%-31.98% 4.03B
+0.37%+1.27%-21.26%-40.73% 3.31B
+0.49%-1.33%+5.75%-36.68% 3.14B
-0.16%+0.97%-42.58%-22.84% 3.12B
-0.39%-1.74%-13.05%+4.55% 2.64B
-0.69%-3.18%+100.05% - 2.57B
Average -9.03%-0.69%-6.14%-24.95% 5.36B
Weighted average by Cap. -1.08%+0.57%-14.87%-25.93%

Financials

2026 *2027 *
Net sales 1.24B 1.53B 1.33B 1.14B 2.15B 145B 2.17B 14.58B 5.7B 72.64B 5.74B 5.61B 241B 1.39B 1.72B 1.49B 1.28B 2.41B 163B 2.44B 16.37B 6.4B 81.58B 6.44B 6.3B 270B
Net income -81.01M -100M -86.88M -74.42M -141M -9.52B -142M -955M -373M -4.76B -376M -368M -15.77B -43.68M -53.95M -46.84M -40.12M -75.88M -5.13B -76.72M -515M -201M -2.57B -203M -198M -8.5B
Net Debt 200M 247M 215M 184M 348M 23.51B 351M 2.36B 922M 11.75B 928M 908M 38.94B 236M 291M 253M 217M 410M 27.72B 414M 2.78B 1.09B 13.86B 1.09B 1.07B 45.92B
Logo DocMorris AG
DocMorris AG, formerly Zur Rose Group AG, is a Switzerland-based company engaged in the drug distribution sector. The Company focuses on the wholesale trade of medicines, as well as operation of a mail-order pharmacy. DocMorris operates at the healthcare, technology and e-commerce, with a primary focus on customer-centric digital healthcare and improving medication efficacy. core business is online pharmacy. In addition to prescription medicines (Rx), assortment features over-the-counter (OTC) and consumer health as well as beauty and personal care (BPC) products. Private labels, including nutritional supplements, painkillers, first-aid products and other OTC medicines. The Company's operates under brands such as PromoFarma, DoctiPharma, Apotal, Medpex and Teleclinic, among others
Employees
-
Trader
Investor
-
Global
-
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
9
Last Close Price
10.16CHF
Average target price
10.22CHF
Spread / Average Target
+0.58%

Quarterly revenue - Rate of surprise